Rohit Loomba (@DrLoomba) / X

Rohit Loomba

3,877 posts

Rohit Loomba

@DrLoomba

Liver doctor/Professor of Medicine/clinical trial design Phase 1-4/inventor/drug developer/life's goal to find a cure for liver fibrosis & NASH.

San Diego, California

Joined December 2011

Rohit Loomba
@DrLoomba
May 30, 2023
I am truly honored and humbled to serve as the next Division of Gastroenterology and Hepatology @UCSDGI at @UCSDHealthSci where I trained as a GI fellow! Grateful to the entire team @UCSDHealthSci @pattymaysent @CALonghurst @UCSDMedSchool @jeannabryn @AASLDtweets @AmerGastroAssn
UCSD Gastroenterology
@UCSD_GI
May 30, 2023
It’s official! After an extensive national search, we are beyond excited to announce that our very own @DrLoomba will be our next Division Chief of @UCSD_GI !
54K
Rohit Loomba
@DrLoomba
Mar 17, 2023
SEMAGLUTIDE in Cirrhosis: Significant improvement in ALT and AST and MRI-PDFF with SEMA in cirrhosis-- need longer, larger studies and combination Rx in cirrhosis @UCSD_GI @NAFLDresearch @EASLedu @AASLDtweets @phil_newsome7 @mromerogomez @ebtapper @NoureddinMD @pattymaysent
The Lancet Gastroenterology & Hepatology
@LancetGastroHep
Mar 17, 2023
New research - Loomba et al - Semaglutide 2·4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trial thelancet.com/journals/langa… #NASH #NAFLD #cirrhosis #gitwitter #livertwitter #medtwitter @DrLoomba
22K
Rohit Loomba
@DrLoomba
Nov 15, 2023
Grateful for the past (mentors & mentees), present team @NAFLDresearch @UCSD_GI and future (mentees who will be joining the team) to be listed among top cited 🌐 Clarivate Reveals World's Influential Researchers in Highly Cited Researchers 2023 List prn.to/3QYYM8P
12K
Rohit Loomba
@DrLoomba
Oct 17, 2022
I love my team and so grateful to them ⁦@NAFLDresearch⁩ ⁦@UCSDHealth⁩ !! It was the best birthday— Got to clinic & everyone wished me with a smile and then got to office team had a cake 🎂 & decorations all over— just one word that describes how I feel— Gratitude🙏
Rohit Loomba
@DrLoomba
Nov 15, 2022
Honored and humbled to be included among highly Cited Researchers™ that are 1 in 1,000 and are top 6,938 Highly Cited Researchers in 2022! clarivate.com/highly-cited-r… Gratitude team @NAFLDresearch @UCSDHealthSci @pattymaysent @CALonghurst @SDDRC @ucsdactri @AASLDtweets @NIDDKgov
Rohit Loomba
@DrLoomba
Feb 16, 2022
Congratulations Arun Sanyal and Todd Stravitz for establishing a visionary liver institute--- Very inspirational and very well-deserved recognition!! @AASLDtweets Virginia Commonwealth University receives record $104 million donation for liver research
Virginia Commonwealth University receives record $104 million donation for liver research
From washingtonpost.com
Rohit Loomba
@DrLoomba
Mar 14, 2024
Resmetirom approved for Rx of NASH related fibrosis- 1st FDA approved Rx for one of the biggest untapped therapeutic areas by @MadrigalPharma !!! @AASLDtweets @AmerGastroAssn Madrigal granted FDA approval for NASH therapy msn.com/en-us/health/o…
6.6K
Rohit Loomba
@DrLoomba
Aug 9, 2024
Four years of work- Key paper to read Prevalence of steatotic liver disease, advanced fibrosis and cirrhosis among community-dwelling overweight and obese individuals in the USA gut.bmj.com/content/early/… @AASLDtweets @EASLnews @INASL_Liver @DrHuangDQ @f_tavaglione @UCSD_GI
8.8K
Rohit Loomba
@DrLoomba
Aug 8, 2024
Honored & humbled to be the recipient of the prestigious Dr. DV Datta Memorial Oration at 32nd ⁦@INASL_Liver⁩ meeting in Kochi - 🙏 ⁦@ajay_duseja⁩ ⁦@shivaramsingh⁩ — Tx to ⁦@MASLDResearch⁩ ⁦@UCSD_GI⁩ for the work I discussed ⁦@AASLDtweets⁩
7.1K
Rohit Loomba
@DrLoomba
Apr 4, 2023
Emerging role of statin therapy in the prevention and management of cirrhosis, portal hypertension, and HCC pubmed.ncbi.nlm.nih.gov/37013380/ @AASLDtweets @HEP_Journal @SuzanneSharpton @NAFLDresearch @UCSDHealth @SDDRC @nagachalasani @AlkhouriNaim @ebtapper #livertwitter @Dr_Vijay_Shah
Emerging role of statin therapy in the prevention and management of cirrhosis, portal hypertension,...
From pubmed.ncbi.nlm.nih.gov
12K
Rohit Loomba
@DrLoomba
Jun 24, 2023
Appreciate the collaborative effort of the entire study group and co-authors in achieving these positive results in NASH Phase 2b RCT of pegozafermin versus placebo - @NAFLDresearch @AmerGastroAssn @EASLnews @AASLDtweets @pattymaysent @CALonghurst @QAnstee @juanpabloarab
NEJM
@NEJM
Jun 24, 2023
Late breaking at #EASLCongress: In this phase 2b, placebo-controlled trial involving patients with nonalcoholic steatohepatitis, pegozafermin, a long-acting glycopegylated FGF21 analogue, reduced fibrosis at 24 weeks. Full results by @DrLoomba et al.: nej.md/3NF5sHF
12K
Rohit Loomba
@DrLoomba
Sep 22, 2022
Congratulations, Dr. John Carethers, who will be joining UCSD as the Vice Chancellor of Health Sciences!! We are super-excited and delighted to have him back at UCSD! @UCSDHealthSci @UCSDHealth @NAFLDresearch @pattymaysent @CALonghurst @AmerGastroAssn
Rohit Loomba
@DrLoomba
Feb 5, 2024
At our local news station talking about MASLD in San Diego and new treatments ⁦@KUSINews⁩ ⁦@fox5sandiego⁩ with ⁦@AshleyJacobsTV⁩ — increasing awareness regarding MASH ⁦@AASLDtweets⁩ ⁦@UCSD_GI⁩ ⁦@pattymaysent⁩ ⁦@CALonghurst⁩
4.1K
Rohit Loomba
@DrLoomba
Jun 30, 2023
Super proud of outstanding visiting scholar who broke all previous records of publication ⁦@NAFLDresearch⁩ - talented ⁦@DrHuangDQ⁩ for completing his 2 yr now returning to Singapore- 🙏 to be your mentor ⁦@EASLnews⁩ ⁦@AmerGastroAssn⁩ ⁦@AASLDtweets⁩
4K